Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 109786601000001112 | Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 109786701000001119 | Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | Is a | Product containing magnesium alginate and sodium alginate | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | Has active ingredient | Sodium alginate | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | Has active ingredient | Magnesium alginate | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | Has dispensed dose form | Drug powder | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | Has specific active ingredient | Sodium alginate | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | Has specific active ingredient | Magnesium alginate | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | Is a | Virtual medicinal product | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free 15 dual dose sachet | Has VMP | False | Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | Inferred relationship | Existential restriction modifier | |
| Gaviscon Infant oral powder sachets (Reckitt Benckiser Plc) | Is a | False | Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachets sugar free | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR